New Publications

In the months of February – March 2022, we published 120 publications

Make yourself familiar with our Research Publication Authorship, Affiliation and Acknowledgements Policy (NSWHP_PD_026).

Make your publication count:

All NSW Health Pathology author affiliation must include the following elements in the following order;

  1. The name of the clinical service or specialty;
  2. NSW Health Pathology (not New South Wales Health Pathology or NSW Pathology);
  3. Location of the service or specialty;
  4. and any additional partnership affiliations (where applicable);
  5. City and State, Country.

For example: 

1Microbiology, NSW Health Pathology, Westmead Hospital and Institute of Clinical Pathology and Medical Research, Westmead, NSW, Australia. 

 

MAY 2022

  1. Dermoscopic features and screening strategies for the detection of small-diameter melanomas. Regio Pereira A, Corral-Forteza M, Collgros H, El Sharouni MA, Ferguson PM, Scolyer RA, Guitera P. Clin Exp Dermatol. 2022 May;47(5):932-941. Q2 Dermatology (SJR).
  2. Comparison of six regression-based lot-to-lot verification approaches. Koh NWX, Markus C, Loh TP, Lim CY. Clin Chem Lab Med. 2022 May 16. Q1 Biochemistry (medical (SJR)).
  3. Antibiotic Prescribing and Antimicrobial Resistance from an Australian Perspective. Merlino J, Siarakas S. Microb Drug Resist. 2022 May;28(5):536-538. Q2 Medicine (miscellaneous (SJR)).
  4. Herbal tea and hypoadrenalism. Morton A, Ruddell R, Treacy O. Aust J Gen Pract. 2022 May;51(5):353-355. Q2 Family Practice (SJR).
  5. The WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Lobo J, Ohashi R, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, Menon S, Netto GJ, Raspollini MR, Rubin MA, Tan PH, Tickoo SK, Tsuzuki T, Turajlic S, Zhou M, Srigley JR, Moch H. Histopathology. 2022 May 21. Q1 Histology (SJR). Q1 Histology (SJR).
  6. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Eden JS, Sikazwe C, Xie R, Deng YM, Sullivan SG, Michie A, Levy A, Cutmore E, Blyth CC, Britton PN, Crawford N, Dong X, Dwyer DE, Edwards KM, Horsburgh BA, Foley D, Kennedy K, Minney-Smith C, Speers D, Tulloch RL, Holmes EC, Dhanasekaran V, Smith DW, Kok J, Barr IG; Australian RSV study group. Nat Commun. 2022 May 24;13(1):2884. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  7. Achieving safe surgery after COVID-19 vaccination. Kovoor JG, Jacobsen JHW, Duncan J, Addo AA, Tivey DR, Babidge WJ, Penn D, Churchill J, Collinson TG, Kok J, Kelly S, Lu VH, Beavis VS, MacCormick AD, Kearney BJ, Gowans EJ, Hewett PJ, Hugh TJ, Woo HH, Padbury RT, Scott DA, Frydenberg M, Maddern GJ. ANZ J Surg. 2022 May;92(5):946-949. Q2 Surgery (SJR).
  8. Arterial thrombosis following first-dose ChAdOx1 vaccination: a case series. Chatterton S, Mason GA, Cook R, Davidson K, Ward C, Ng K. BMJ Neurol Open. 2022 May 6;4(1):e000270. Q3 Neurology (SJR).
  9. Delayed Acetaminophen Absorption Resulting in Acute Liver Failure. Tan H, Stathakis P, Varghese B, Buckley NA, Chiew AL. Case Rep Crit Care. 2022 May 7; 2022:3672248. Q3 Critical Care and Intensive Care Medicine (SJR).
  10. A Guide to the Postmortem Investigation of Starvation in Adults. Garland J, Irvine R. Am J Forensic Med Pathol. 2022 May 19. Q3 Medicine (miscellaneous (SJR)).
  11. Immunohistochemistry for FOSB and FOS is a Useful Ancillary Tool in the Diagnosis of Epithelioid Hemangioma but There are Pitfalls in Interpretation Including Expression in Other Vascular Lesions. Tsui KY, Maclean F, Moir D, Cheah A, Bonar F, Tabot J, Gill AJ, Vargas AC. Int J Surg Pathol. 2022 May 29:10668969221101867. Q2 Anatomy (SJR).
  12. Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance. Rockett RJ, Draper J, Gall M, Sim EM, Arnott A, Agius JE, Johnson-Mackinnon J, Fong W, Martinez E, Drew AP, Lee C, Ngo C, Ramsperger M, Ginn AN, Wang Q, Fennell M, Ko D, Hueston L, Kairaitis L, Holmes EC, O'Sullivan MN, Chen SC, Kok J, Dwyer DE, Sintchenko V. Nat Commun. 2022 May 18;13(1):2745. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  13. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas. Ahadi MS, Fuchs TL, Clarkson A, Sheen A, Sioson L, Chou A, Gill AJ. Histopathology. 2022 May;80(6):906-921. Q1 Histology (SJR).
  14. Emergence of de novo cutaneous vasculitis post coronavirus disease (COVID-19) vaccination. Liang I, Swaminathan S, Lee AYS. Clin Rheumatol. 2022 May;41(5):1611-1612. Q1 Medicine (miscellaneous (SJR)).
  15. Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Choi PY, Hsu D, Tran HA, Tan CW, Enjeti A, Chen VMY, Chong BH, Curnow J, Pepperell D, Bird R. Haematologica. 2022 May 1;107(5):1193-1196. Q1 Hematology (SJR).
  16. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia. Aggarwal A, Stella AO, Walker G, Akerman A, Esneau C, Milogiannakis V, Burnett DL, McAllery S, Silva MR, Lu Y, Foster CSP, Brilot F, Pillay A, Van Hal S, Mathivanan V, Fichter C, Kindinger A, Hoppe AC, Munier ML, Amatayakul-Chantler S, Roth N, Coppola G, Symonds GP, Schofield P, Jackson J, Lenthall H, Henry JY, Mazigi O, Jäck HM, Davenport MP, Darley DR, Matthews GV, Khoury DS, Cromer D, Goodnow CC, Christ D, Robosa R, Starck DJ, Bartlett NW, Rawlinson WD, Kelleher AD, Turville SG. Nat Microbiol. 2022 Jun;7(6):896-908. Q1 Applied Microbiology and Biotechnology (SJR).
  17. EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections. Sprute R, Bethe U, Chen SC, Cornely OA. J Antimicrob Chemother. 2022 May 29;77(6):1779-1784. Q1 Infectious Diseases (SJR).
  18. Citizen Science Mosquito Surveillance by Ad Hoc Observation Using the iNaturalist Platform. Braz Sousa L, Fricker S, Webb CE, Baldock KL, Williams CR. Int J Environ Res Public Health. 2022 May 23;19(10):6337. Q1 Health, Toxicology and Mutagenesis (SJR).
  19. Bullous neutrophilic dermatosis with severe acral oedema post-COVID-19 mRNA vaccination. Goubar T, Star P, Donlon J, Gilbey T, Smith A. Australas J Dermatol. 2022 May;63(2):e175-e177. Q2 Dermatology (SJR).
  20. Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. Pennington TE, Zhao CY, Colebatch AJ, Fernandez-Peñas P, Guitera P, Burke H, Scolyer RA, Menzies AM, Carlino MS, Lo S, Long GV, Saw RP. Australas J Dermatol. 2022 May;63(2): e133-e137. Q2 Dermatology (SJR).
  21. Voriconazole in hematopoietic stem cell transplantation and cellular therapies: Real-world usage and therapeutic level attainment at a major transplant center. Lindsay J, Krantz EM, Morris J, Sweet A, Tverdek F, Joshi A, Yeh R, Hill JA, Greenwood M, Chen SC, Kong DCM, Slavin M, Pergam SA, Liu C. Transplant Cell Ther. 2022 May 24: S2666-6367(22)01323-9.
  22. PD-L1 expression as a prognostic marker in patients treated with chemotherapy for metastatic non-small-cell lung cancer. Woodford R, Zhou D, Lord SJ, Marschner I, Cooper WA, Lewis CR, John T, Yang JC, Lee CK. Future Oncol. 2022 May;18(14):1793-1799. Q2 Medicine (miscellaneous (SJR)).
  23. Cancer patients spend more time at home and more often die at home with advance care planning conversations in primary health care: a retrospective observational cohort study. Driller B, Talseth-Palmer B, Hole T, Strømskag KE, Brenne AT. BMC Palliat Care. 2022 May 2;21(1):61. Q1 Medicine (miscellaneous (SJR)).
  24. Correspondence on "Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)" by Gregg et al. Righetti S, Dive L, Archibald AD, Freeman L, McClaren B, Kanga-Parabia A, Delatycki MB, Laing NG, Kirk EP, Newson AJ; counselling, psycho-social, and implementation science teams at Mackenzie’s Mission and the Gene Selection Committee. Genet Med. 2022 May;24(5):1158-1161. Q1 Genetics (clinical (SJR)).
  25. Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. Steinberg J, Chan P, Hogden E, Tiernan G, Morrow A, Kang YJ, He E, Venchiarutti R, Titterton L, Sankey L, Pearn A, Nichols C, McKay S, Hayward A, Egoroff N, Engel A, Gibbs P, Goodwin A, Harris M, Kench JG, Pachter N, Parkinson B, Pockney P, Ragunathan A, Smyth C, Solomon M, Steffens D, Toh JWT, Wallace M, Canfell K, Gill A, Macrae F, Tucker K, Taylor N. Hered Cancer Clin Pract. 2022 May 4;20(1):18. Q3 Genetics (clinical (SJR)).
  26. ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo. Law AMK, Chen J, Colino-Sanguino Y, Fuente LR, Fang G, Grimes SM, Lu H, Huang RJ, Boyle ST, Venhuizen J, Castillo L, Tavakoli J, Skhinas JN, Millar EKA, Beretov J, Rossello FJ, Tipper JL, Ormandy CJ, Samuel MS, Cox TR, Martelotto L, Jin D, Valdes-Mora F, Ji HP, Gallego-Ortega D. Adv Sci (Weinh). 2022 May 25: e2103332. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  27. Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
  28. Gottlieb DJ, Sutrave G, Jiang W, Avdic S, Street JA, Simms R, Clancy LE, Antonenas V, Gloss BS, Bateman C, Bishop DC, Micklethwaite KP, Blyth E. Am J Hematol. 2022 May 12. Q1 Hematology (SJR).
  29. Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spread. Li AT, Miin Yip J, Choksi H, London K, Potter AJ, Lo SN, Saw RPM, Shannon KF, Pires da Silva I, Varey AHR, Menzies AM, Long GV, Shivalingam B, Scolyer RA, Thompson JF, Ch'ng S. Melanoma Res. 2022 May 13. Q1 Dermatology (SJR).
  30. Evaluation of chlorhexidine sensitization amongst healthcare workers. Anderson J, Fulton RB, Li J, Cheng I, Fernando SL. Occup Med (Lond). 2022 May 26: kqac038. Q2 Medicine (miscellaneous (SJR)).
  31. Intravenous immunoglobulin infusion contributes to a high incidence of false reactive screen results for human T-lymphotropic virus. Luo I, Bradhurst P, Chen R. Pathology. 2022 May 6: S0031-3025(22)00127-1. Q1 Pathology and Forensic Medicine (SJR).
  32. Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care. Ariens J, Horvath AR, Yang J, Choy KW. Endocrine. 2022 May 27. Q2 Endocrinology (SJR).
  33. Anti-Endothelial Cell Antibodies are not frequently elevated in hospitalized patients with COVID-19. Henry B, Benoit S, Vikse J, Favaloro E, Benoit J, Lippi G. Acta Biomed. 2022 May 11;93(2): e2022043. Q2 Medicine (miscellaneous (SJR)).
  34. Priorities in Biobanking Research: A Report on the 2021 ISBER Round Table. Byrne JA, Banaszak AT, Carpenter JE, Carroll SL, Castelhano MG, Espinal PS, Henderson MK, Hettiaratchi A, Maseme M, Ng W, Patel K, Popescu I, Prada SI, Schleif WS, Smith M, Wee S, Weil CJ, Woods K. Biopreserv Biobank. 2022 May 4. Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  35. Multidrug-resistant OXA-48/CTX-M-15 Klebsiella pneumoniae cluster in a COVID-19 Intensive Care Unit: Salient lessons for infection prevention and control during the COVID-19 pandemic. Howard-Jones AR, Sandaradura I, Robinson R, Orde SR, Iredell J, Ginn A, van Hal S, Branley J. J Hosp Infect. 2022 May 10: S0195-6701(22)00130-X. Q1 Infectious Diseases (SJR).
  36. Recursive Partitioning to Determine Order of Significance of Regional Metastasis Characteristics in Head and Neck Cutaneous Squamous Cell Carcinoma. Hurrell MJL, Heller GZ, Elliott MS, Gao K, Ebrahimi A, Clark JR, Shannon K, Palme CE, Wykes J, Gupta R, Ch'ng S, Nguyen KM, Low TH. Ann Surg Oncol. 2022 May 15. Q1 Surgery (SJR).
  37. Intra-thoracic tuberculosis lymphadenitis in a child with rheumatic heart disease. Al Abdali K, Britton PN, Howard-Jones AR, Kesson AM, Marais BJ. J Paediatr Child Health. 2022 May;58(5):918-920. Q2 Pediatrics, Perinatology and Child Health (SJR).
  38. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients. El Sharouni MA, Scolyer RA, van Gils CH, Ch'ng S, Nieweg OE, Pennington TE, Saw RP, Shannon K, Spillane A, Stretch J, Witkamp AJ, Sigurdsson V, Thompson JF, van Diest PJ, Lo SN. Eur J Cancer. 2022 May; 167:133-141. Q1 Cancer Research (SJR).
  39. Serum Thrombospondin-2 Levels Are Closely Associated with the Severity of Metabolic Syndrome and Metabolic Associated Fatty Liver Disease. Wu X, Cheung CKY, Ye D, Chakrabarti S, Mahajan H, Yan S, Song E, Yang W, Lee CH, Lam KSL, Wang C, Xu A. J Clin Endocrinol Metab. 2022 May 9: dgac292. Q1 Biochemistry (SJR).
  40. Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes. El Sharouni MA, Scolyer RA, van Gils CH, Ch'ng S, Nieweg OE, Pennington TE, Saw RPM, Shannon K, Spillane A, Stretch J, Witkamp AJ, Sigurdsson V, Thompson JF, van Diest PJ, Lo SN. Eur J Cancer. 2022 May; 167:123-132. Q1 Cancer Research (SJR).
  41. Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes. Garg M, Couturier DL, Nsengimana J, Fonseca NA, Wongchenko M, Yan Y, Lauss M, Jönsson GB, Newton-Bishop J, Parkinson C, Middleton MR, Bishop DT, McDonald S, Stefanos N, Tadross J, Vergara IA, Lo S, Newell F, Wilmott JS, Thompson JF, Long GV, Scolyer RA, Corrie P, Adams DJ, Brazma A, Rabbie R. Nat Commun. 2022 May 17;13(1):2841. Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous (SJR)).
  42. Life-threatening barium carbonate poisoning managed with intravenous potassium, continuous veno-venous haemodialysis and endoscopic removal of retained ceramic glazes. Jamshidi N, Dhaliwal N, Hearn D, McCalman C, Wenzel R, Koutsogiannis Z, Roberts DM. Clin Toxicol (Phila). 2022 May 4:1-5. Q2 Medicine (miscellaneous (SJR)).
  43. Competing risks analysis with missing cause-of-failure-penalized likelihood estimation of cause-specific Cox models. Lô SN, Ma J, Manuguerra M, Moreno-Betancur M, Scolyer RA, Thompson JF. Stat Methods Med Res. 2022 May;31(5):978-994. Q1 Health Information Management (SJR).
  44. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study. Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard Jones R, Sondak VK, Thompson JF, Zager JS. Ann Surg Oncol. 2022 May 13. Q1 Surgery (SJR).
  45. Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'. Guitera P, Waddell A, Paton E, Fogarty GB, Hong A, Scolyer RA, Stretch JR, O'Donnell BA, Pellacani G. Australas J Dermatol. 2022 May;63(2): e198-e199. Q2 Dermatology (SJR).
  46. Mild encephalitis/encephalopathy with reversible splenial lesion in association with Staphylococcus aureus bacteraemia. Howard-Jones AR, Britton PN, Webster R, Ayer J, Khatami A. J Paediatr Child Health. 2022 May;58(5):913-917. Q2 Pediatrics, Perinatology and Child Health (SJR).
  47. Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia. Kim KW, Wang X, Adhikari A, Yeang M, Jenkins F, Naing Z, Walker GJ, Foster CSP, Stelzer-Braid S, Deveson I, Craig ME, Tedla N, Bull RA, Martinello M, Pinto AN, Chan R, Turville S, Rawlinson WD, van Hal S. J Med Virol. 2022 May 4. Q1 Infectious Diseases (SJR).
  48. Squamous cell carcinoma differentiation at progression as a resistance mechanism in metastatic non-small cell lung carcinoma harbouring a targetable mutation. Heynemann S, Prosser N, Lee J, Mahar A, Anderson L, Kao S, Cooper WA. Pathology. 2022 May 12: S0031-3025(22)00128-3. Q1 Pathology and Forensic Medicine (SJR).
  49. ASO Visual Abstract: Evaluation of Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International Multicenter Study. Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Jones RP, Sondak VK, Thompson JF, Zager JS. Ann Surg Oncol. 2022 May 25. Q1 Surgery (SJR).
  50. Performance of Pyrethroid-Neonicotinoid Mixture Formulations Against Field-Collected Strains of the Tropical Bed Bug (Hemiptera: Cimicidae) on Different Substrates. Dang K, Doggett SL, Lee CY. J Econ Entomol. 2022 May 26: toac068. Q1 Insect Science (SJR).
  51. Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing. Favaloro EJ, Lay M, Mohammed S, Vong R, Pasalic L. Pathology. 2022 May 27: S0031-3025(22)00138-6. Q1 Pathology and Forensic Medicine (SJR).
  52. ASO Visual Abstract: Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck. Yung AE, Crouch G, Varey AHR, Lo S, Elliott MS, Lee J, Rawson R, Gupta R, Hong AM, Clark JR, Ch'ng S. Ann Surg Oncol. 2022 May 6. Q1 Surgery (SJR).
  53. The Efficacy of a Pyrethroid-impregnated Mattress Liner on Multiple International Strains of Cimex lectularius (Hemiptera: Cimicidae) and Cimex hemipterus (Hemiptera: Cimicidae). Leong XY, Lee CY, Veera Singham G, Chong Shu-Chien A, Naylor R, Naylor A, Miller DM, Wilson MM, Lilly DG, Doggett SL. J Econ Entomol. 2022 May 29: toac067. Q1 Insect Science (SJR).

 

APRIL 2022

  1. Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry (MelCOR): A modified Delphi study. Jobson D, Roffey B, Arnold C, Azzi A, Button-Sloan A, Dawson T, Fernandez-Penas P, Fishburn P, Gyorki DE, Hiscutt EL, Jakrot V, Lilleyman A, Lochhead A, Long GV, Mailer S, Mann G, McCormack CJ, Muir J, Pratt GF, Scolyer RA, Shackelton M, Shumack S, Soyer HP, Tan CG, Webb A, Zalcberg J, Morton R, Mar V. Australas J Dermatol. 2022 Apr 29. Q2 Dermatology (SJR).
  2. Long-term sequelae of a misplaced intrauterine contraceptive device. Mugino M, MacDermid E, Morgan MJ, Langan R. ANZ J Surg. 2022 Apr 29. Q3 Medicine (miscellaneous (SJR)).
  3. Fulminant Delta COVID-19 myocarditis: a case report of fatal primary cardiac dysfunction. Thomson A, Totaro R, Cooper W, Dennis M. Eur Heart J Case Rep. 2022 Apr 13;6(4):ytac142. Q3 Cardiology and Cardiovascular Medicine (SJR).
  4. Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma. Minaei E, Mueller SA, Ashford B, Thind AS, Mitchell J, Perry JR, Genenger B, Clark JR, Gupta R, Ranson M. Front Oncol. 2022 Apr 11; 12: 835929.
  5. Bladder cancer survival in patients with NOD2 or CDKN2A variants. Złowocka-Perłowska E, van de Wetering T, Tołoczko-Grabarek A, Scott RJ, Lubiński J. Oncotarget. 2022 Apr 22;13:628-640.
  6. Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2021. Lahra MM, Shoushtari M, Hogan TR. Commun Dis Intell (2018). 2022 Apr 26;46.
  7. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2021. Lahra MM, Shoushtari M, Hogan TR. Commun Dis Intell (2018). 2022 Apr 26;46.
  8. The Availability of Human Biospecimens to Support Biomarker Research. Tarling TE, Byrne JA, Watson PH. Biomark Insights. 2022 Apr 19;17: 11772719221091750.
  9. TNFAIP3 Reduction-of-Function Drives Female Infertility and CNS Inflammation.
  10. Zammit NW, McDowell J, Warren J, Muskovic W, Gamble J, Shi YC, Kaczorowski D, Chan CL, Powell J, Ormandy C, Brown D, Oakes SR, Grey ST. Front Immunol. 2022 Apr 8; 13:811525.
  11. Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm- overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement. Enjeti AK, Agarwal R, Blombery P, Chee L, Chua CC, Grigg A, Hamad N, Iland H, Lane S, Perkins A, Singhal D, Tate C, Tiong IS, Ross DM. Pathology. 2022 Apr 20:S0031-3025(22)00122-2.
  12. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput. Phan T, Tran NYK, Gottlieb T, Siarakas S, McKew G. Pathology. 2022 Apr 20: S0031-3025(22)00119-2.
  13. Reproductive Genetic Carrier Screening and Inborn Errors of Metabolism: the voice of the IEM community needs to be heard. Kirk EP, Delatycki MB, Laing N. J Inherit Metab Dis. 2022 Apr 22.
  14. Expression of NGF/proNGF and Their Receptors TrkA, p75NTR and Sortilin in Melanoma. Marsland M, Dowdell A, Jiang CC, Wilmott JS, Scolyer RA, Zhang XD, Hondermarck H, Faulkner S. Int J Mol Sci. 2022 Apr 12;23(8):4260.
  15. Fecal DNA Virome Is Associated with the Development of Colorectal Neoplasia in a Murine Model of Colorectal Cancer. Li Y, Zhang F, Zheng H, Kalasabail S, Hicks C, Fung KY, Preaudet A, Putoczki T, Beretov J, Millar EKA, El-Omar E, Jiang XT, Yim HCH. Pathogens. 2022 Apr 11;11(4):457.
  16. The Australian dingo is an early offshoot of modern breed dogs. Field MA, Yadav S, Dudchenko O, Esvaran M, Rosen BD, Skvortsova K, Edwards RJ, Keilwagen J, Cochran BJ, Manandhar B, Bustamante S, Rasmussen JA, Melvin RG, Chernoff B, Omer A, Colaric Z, Chan EKF, Minoche AE, Smith TPL, Gilbert MTP, Bogdanovic O, Zammit RA, Thomas T, Aiden EL, Ballard JWO. Sci Adv. 2022 Apr 22;8(16): eabm5944.
  17. Metatranscriptomic analysis of host response and vaginal microbiome of patients with severe COVID-19. Xiao M, Lu B, Ding R, Liu X, Wu X, Li Y, Liu X, Qiu L, Zhang Z, Xie J, Chen Y, Zhang D, Dong L, Zhang M, Peng J, Yang H, Kudihna T, Xu Y, Li T, Yi C, Zhu L. Sci China Life Sci. 2022 Apr 14:1-4.
  18. SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability. Foster CSP, Madden M, Chan R, Agapiou D, Bull RA, Rawlinson WD, Van Hal SJ. Pathology. 2022 Apr 16: S0031-3025(22)00117-9.
  19. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories. Lau KA, Kaufer A, Gray J, Theis T, Rawlinson WD. Pathology. 2022 Apr 16: S0031-3025(22)00116-7.
  20. Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi. Colebatch AJ, Adhikari C, Diefenbach RJ, Rawson RV, Ferguson PM, Rizos H, Long GV, McCarthy SW, Thompson JF, Wilmott JS, Scolyer RA. Am J Surg Pathol. 2022 Apr 20.
  21. Electronic alerts and a care bundle for acute kidney injury - an Australian cohort study. Kotwal S, Herath S, Erlich J, Boardman S, Qian J, Lawton P, Campbell C, Whatnall A, Teo S, Horvath AR, Endre ZH. Nephrol Dial Transplant. 2022 Apr 19:gfac155.
  22. Rapid FISH results within one hour. Wren C, Tegg E. Cancer Genet. 2022 Apr 8;264-265:66-70.
  23. Oral Epithelial Dysplasia: A Review of Diagnostic Criteria for Anatomic Pathologists. Cheung VKY, Hulme K, Schifter M, Palme C, Low TH, Clark J, Gupta R. Adv Anat Pathol. 2022 Apr 19.
  24. Effect of the SunSafe Training Program on the attitudes, knowledge, and behaviour of Australian high school students towards sun safety: a prospective study. Hanna S, Marinos E, Bryan D, Ahmed T, Lo SN, Carlino MS, Smith A, Cairns G, Shannon K, Long GV, Scolyer RA, Saw RPM. Clin Exp Dermatol. 2022 Apr 18.
  25. Treatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation. Lindsay J, Greenwood M, Othman J, Chen SC, Kong DCM, Pergam SA, Liu C, Slavin MA. Leuk Lymphoma. 2022 Apr 15:1-3.
  26. VEXAS syndrome: lessons learnt from an early Australian case series. Islam S, Cullen T, Sumpton D, Damodaran A, Heath D, Bosco A, Doo NW, Kidson-Gerber G, Cheong A, Lawford R, Walsh R, Sammel A. Intern Med J. 2022 Apr;52(4):658-662.
  27. Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck. Yung AE, Crouch G, Varey AHR, Lo S, Elliott MS, Lee J, Rawson R, Gupta R, Hong AM, Clark JR, Ch'ng S. Ann Surg Oncol. 2022 Apr 13.
  28. Anti-tissue transglutaminase (tTG) screening using relative light units to identify IgA deficiency. Wijaya C, Lemmert K, De Malmanche T. Pathology. 2022 Apr 6:S0031-3025(22)00110-6.
  29. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, et al. Nature. 2022 Apr;604(7906):502-508.
  30. Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome. Stephenson SEM, Costain G, Blok LER, Silk MA, Nguyen TB, Dong X, Alhuzaimi DE, Dowling JJ, Walker S, Amburgey K, Hayeems RZ, Rodan LH, Schwartz MA, et al. Am J Hum Genet. 2022 Apr 7;109(4):601-617.
  31. Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection. Jonker PKC, Metman MJH, Sondorp LHJ, Sywak MS, Gill AJ, Jansen L, Links TP, van Diest PJ, van Ginhoven TM, Löwik CWGM, Nguyen AH, Coppes RP, Robinson DJ, van Dam GM, van Hemel BM, Fehrmann RSN, Kruijff S. Eur J Nucl Med Mol Imaging. 2022 Apr 7.
  32. scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs. Hunt KV, Burnard SM, Roper EA, Bond DR, Dun MD, Verrills NM, Enjeti AK, Lee HJ. Sci Rep. 2022 Apr 6;12(1):5776.
  33. Clinical use of anti-histone antibodies in idiopathic and drug-induced lupus. Lee AYS. Immunol Med. 2022 Apr 6:1-6.
  34. Donor T cells for CAR T cell therapy. Tang TCY, Xu N, Nordon R, Haber M, Micklethwaite K, Dolnikov A. Biomark Res. 2022 Apr 1;10(1):14.
  35. Anatomic position determines oncogenic specificity in melanoma. Weiss JM, Hunter MV, Cruz NM, Baggiolini A, Tagore M, Ma Y, Misale S, Marasco M, Simon-Vermot T, Campbell NR, Newell F, Wilmott JS, Johansson PA, Thompson JF, Long GV, Pearson JV, Mann GJ, Scolyer RA, Waddell N, Montal ED, Huang TH, Jonsson P, Donoghue MTA, Harris CC, Taylor BS, Xu T, Chaligné R, Shliaha PV, Hendrickson R, Jungbluth AA, Lezcano C, Koche R, Studer L, Ariyan CE, Solit DB, Wolchok JD, Merghoub T, Rosen N, Hayward NK, White RM. Nature. 2022 Apr;604(7905):354-361.
  36. "Von Willebrand disease type 2M: Correlation between genotype and phenotype": Comment from Favaloro. Favaloro EJ. J Thromb Haemost. 2022 Apr;20(4):1019-1021.
  37. The association of transradial access and transfemoral access with procedural outcomes in acute ischemic stroke patients receiving endovascular thrombectomy: A meta-analysis. Shaban S, Rastogi A, Phuyal S, Huasen B, Haridas A, Zelenak K, Iacobucci M, Martínez-Galdámez M, Jabbour P, Bhaskar SMM. Clin Neurol Neurosurg. 2022 Apr;215: 107209.
  38. Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use. Rockett R, Basile K, Maddocks S, Fong W, Agius JE, Johnson-Mackinnon J, Arnott A, Chandra S, Gall M, Draper J, Martinez E, Sim EM, Lee C, Ngo C, Ramsperger M, Ginn AN, Wang Q, Fennell M, Ko D, Lim HL, Gilroy N, O'Sullivan MVN, Chen SC, Kok J, Dwyer DE, Sintchenko V. N Engl J Med. 2022 Apr 14;386(15):1477-1479.
  39. An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic. Tang JW, Caniza MA, Dinn M, Dwyer DE, Heraud JM, Jennings LC, Kok J, Kwok KO, Li Y, Loh TP, Marr LC, Nara EM, Perera N, Saito R, Santillan-Salas C, Sullivan S, Warner M, Watanabe A, Zaidi SK. Interface Focus. 2022 Feb 11;12(2):20210079.
  40. Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay. Balgahom R, Ahuja V, Pitman C, Polkinghorne A, Branley J. Pathology. 2022 Apr;54(3):357-358.
  41. Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study. Lerch JM, Pai RK, Brown I, Gill AJ, Jain D, Kővári B, Kushima R, Sheahan K, Slavik T, Srivastava A, Lauwers GY, Langner C. Pathology. 2022 Apr;54(3):262-268.
  42. Lot-to-lot reagent verification: challenges and possible solutions. Loh TP, Sandberg S, Horvath AR. Clin Chem Lab Med. 2022 Feb 22;60(5):675-680.
  43. Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature review. Connolly EA, Bhadri VA, Wake J, Ingley KM, Lewin J, Bae S, Wong DD, Long AP, Pryor D, Thompson SR, Strach MC, Grimison PS, Mahar A, Bonar F, Maclean F, Hong A. Cancer Med. 2022 Apr;11(8):1805-1816.
  44. A cost-effective sample pooling strategy for line blot assay in detecting onconeural antibodies. Chen R, Luo I, Rae M, Huang S. J Immunol Methods. 2022 Apr;503: 113235.
  45. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy. Miyamoto T, Sanford D, Tomuleasa C, Hsiao HH, Olivera LJE, Enjeti AK, Gimenez Conca A, Castillo TBD, Girshova L, Martelli MP, Guvenc B, Delgado A, Duan Y, Garbayo Guijarro B, Llamas C, Lee JH. Leuk Lymphoma. 2022 Apr;63(4):928-938.
  46. Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Pires da Silva I, Ahmed T, McQuade JL, Nebhan CA, Park JJ, Versluis JM, Serra-Bellver P, Khan Y, Slattery T, Oberoi HK, Ugurel S, Haydu LE, Herbst R, Utikal J, Pföhler C, Terheyden P, Weichenthal M, Gutzmer R, Mohr P, Rai R, Smith JL, Scolyer RA, Arance AM, Pickering L, Larkin J, Lorigan P, Blank CU, Schadendorf D, Davies MA, Carlino MS, Johnson DB, Long GV, Lo SN, Menzies AM. J Clin Oncol. 2022 Apr 1;40(10):1068-1080.
  47. "Surgical technique: A novel pedicled periosteal scapular flap to facilitate bone growth in an Ovine model". Ghosh YA, Gupta R, Al Maruf DA, Cheng K, Mukherjee P, Clark JR. J Plast Reconstr Aesthet Surg. 2022 Apr;75(4):1497-1520.
  48. Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma. Reijers ILM, Rawson RV, Colebatch AJ, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Wouters MW, Saw RPM, van Houdt WJ, Zuur CL, Nieweg OE, Ch'ng S, Klop WMC, Spillane AJ, Long GV, Scolyer RA, van de Wiel BA, Blank CU. JAMA Surg. 2022 Apr 1;157(4):335-342.
  49. Incidence of white matter lesions in hospitalized COVID-19 patients: A meta-analysis. Rastogi A, Bhaskar SMM. Microcirculation. 2022 Apr;29(3):e12749.
  50. Genome-wide networks reveal emergence of epidemic strains of Salmonella Enteritidis. Svahn AJ, Chang SL, Rockett RJ, Cliff OM, Wang Q, Arnott A, Ramsperger M, Sorrell TC, Sintchenko V, Prokopenko M. Int J Infect Dis. 2022 Apr;117:65-73.
  51. Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events. Muir CA, Wood CCG, Clifton-Bligh RJ, Long GV, Scolyer RA, Carlino MS, Menzies AM, Tsang VHM. J Clin Endocrinol Metab. 2022 Apr 19;107(5): e1843-e1849.
  52. Neonatal-lethal dilated cardiomyopathy due to a homozygous LMOD2 donor splice-site variant. Yuen M, Worgan L, Iwanski J, Pappas CT, Joshi H, Churko JM, Arbuckle S, Kirk EP, Zhu Y, Roscioli T, Gregorio CC, Cooper ST. Eur J Hum Genet. 2022 Apr;30(4):450-457.
  53. Hypertriglyceridemia: rationale, design and implementation of the Australian Hypertriglyceridemia Registry. Pang J, Li SCH, Chan DC, Sullivan DR, Woodward AM, Watts GF. Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):131-140.
  54. Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia. Lee CSM, Selvadurai MV, Pasalic L, Yeung J, Konda M, Kershaw GW, Favaloro EJ, Chen VM. J Thromb Haemost. 2022 Apr;20(4):975-988.
  55. Identification of human gene research articles with wrongly identified nucleotide sequences. Park Y, West RA, Pathmendra P, Favier B, Stoeger T, Capes-Davis A, Cabanac G, Labbé C, Byrne JA. Life Sci Alliance. 2022 Jan 12;5(4): e202101203.
  56. BCAS3-Related Neurodevelopmental Disorder Shows Magnetic Resonance Imaging Features Resembling Brain Iron Accumulation. Wong WK, Troedson C, Damme M, Goetti R, Temple SEL, Schöls L, Balousha G, Prelog K, Buckley M, Roscioli T, Hengel H, Mohammad SS. Mov Disord. 2022 Apr;37(4):870-872.
  57. First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction. Ameratunga R, Woon ST, Sheppard MN, Garland J, Ondruschka B, Wong CX, Stewart RAH, Tatley M, Stables SR, Tse RD. J Clin Immunol. 2022 Apr;42(3):441-447.
  58. Supporting urban ecosystem services across terrestrial, marine and freshwater realms. Lowe EC, Steven R, Morris RL, Parris KM, Aguiar AC, Webb CE, Bugnot AB, Dafforn KA, Connolly RM, Mayer Pinto M. Sci Total Environ. 2022 Apr 15; 817: 152689.
  59. Deletion of kif3a in CK19 positive cells leads to primary cilia loss, biliary cell proliferation and cystic liver lesions in TAA-treated mice. Chen J, Cheng NC, Boland JA, Liu K, Kench JG, Watkins DN, Ferreira-Gonzalez S, Forbes SJ, McCaughan GW. Biochim Biophys Acta Mol Basis Dis. 2022 Apr 1;1868(4):166335.
  60. Clinical associations of serum Golgi apparatus antibodies in an immunology laboratory cohort. Lee AYS, Culican S, Campbell D, Lin MW. Scand J Immunol. 2022 Apr;95(4): e13133.
  61. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma. Kang EY, Millstein J, Popovic G, Meagher NS, Bolithon A, Talhouk A, Chiu DS, Anglesio MS, Leung B, Tang K, Lambie N, Pavanello M, Da-Anoy A, et al. Virchows Arch. 2022 Apr;480(4):855-871.
  62. The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. Lippi G, Szergyuk I, de Oliveira MHS, Benoit SW, Benoit JL, Favaloro EJ, Henry BM. J Thromb Thrombolysis. 2022 Apr;53(3):581-585.
  63. Gastrointestinal: Autoimmune enteropathy associated with thymoma. Gu B, Liu K, McKenzie C, MacGregor D, Corte C. J Gastroenterol Hepatol. 2022 Apr;37(4):606.
  64. Phage therapy in pediatrics: the way forward for difficult-to-treat infections? Howard-Jones AR, Iredell JR, Khatami A. Expert Rev Anti Infect Ther. 2022 Apr;20(4):487-491.
  65. Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays. Favaloro EJ, Dean E, Arunachalam S, Vong R, Mohammed S. Pathology. 2022 Apr;54(3):308-317.
  66. Dedifferentiated melanoma with MDM2 gene amplification mimicking dedifferentiated liposarcoma. Yousef S, Joy C, Velaiutham S, Maclean FM, Harraway J, Gill AJ, Vargas AC. Pathology. 2022 Apr;54(3):371-374.
  67. Cutaneous clear cell sarcoma with an epidermal component mimicking melanoma. Potter AJ, Dimitriou F, Karim RZ, Mahar A, Chan C, Long GV, Scolyer RA. Pathology. 2022 Apr;54(3):369-371.
  68. Restricted migration of polyclonal IgG on immunofixation gel electrophoresis in a case of IgG4-related disease. Kakar F, Swaminathan S, Brown DA, Lin MW, McDonald D, Lee AYS. Pathology. 2022 Apr;54(3):367-369.
  69. Building platelet phenotypes: Diaphanous-related formin 1 (DIAPH1)-related disorder. Rabbolini D, Liang HPH, Morel-Kopp MC, Connor D, Whittaker S, Dunkley S, Donikian D, Kondo M, Chen W, Stevenson WS, Campbell H, Joseph J, Ward C, Brighton T, Chen VM; Sydney Platelet Group. Platelets. 2022 Apr 3;33(3):432-442.
  70. Prognostic capacity of hyperdense middle cerebral artery sign in anterior circulation acute ischaemic stroke patients receiving reperfusion therapy: a systematic review and meta-analysis. Shi C, Killingsworth MC, Bhaskar SMM. Acta Neurol Belg. 2022 Apr;122(2):423-435.

 

For earlier publications go to our archived publications here.